Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Histone Deacetylase(HDAC) Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Histone Deacetylase(HDAC) Inhibitorsmarket, defines the market attractiveness level of Histone Deacetylase(HDAC) Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Histone Deacetylase(HDAC) Inhibitors industry, describes the types of Histone Deacetylase(HDAC) Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Histone Deacetylase(HDAC) Inhibitors market and the development prospects and opportunities of Histone Deacetylase(HDAC) Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Histone Deacetylase(HDAC) Inhibitors market in Chapter 13.
By Player:
Karus Therapeutics
Signal Rx
Spectrum Pharmaceuticals
Quimatryx
Gloucester Pharmaceuticals
Pharmacyclics
Ventana Medical Systems
SpeBio
Mirati Therapeutics
Onyx
TetraLogic Pharmaceuticals
By Type:
Hydroxamic Acids
Cyclic Tetrapeptides
Benzamides
Electrophilic Ketones
Aliphatic Acid
By End-User:
Psychiatry and Neurology
Cancer Treatment
HIV
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Histone Deacetylase(HDAC) Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Histone Deacetylase(HDAC) Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Histone Deacetylase(HDAC) Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Histone Deacetylase(HDAC) Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Histone Deacetylase(HDAC) Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Histone Deacetylase(HDAC) Inhibitors Consumption (2017-2022)
-
7.2 United States Histone Deacetylase(HDAC) Inhibitors Consumption (2017-2022)
-
7.3 Europe Histone Deacetylase(HDAC) Inhibitors Consumption (2017-2022)
-
7.4 China Histone Deacetylase(HDAC) Inhibitors Consumption (2017-2022)
-
7.5 Japan Histone Deacetylase(HDAC) Inhibitors Consumption (2017-2022)
-
7.6 India Histone Deacetylase(HDAC) Inhibitors Consumption (2017-2022)
-
7.7 South Korea Histone Deacetylase(HDAC) Inhibitors Consumption (2017-2022)
8 Region and Country-wise Histone Deacetylase(HDAC) Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Histone Deacetylase(HDAC) Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Histone Deacetylase(HDAC) Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Histone Deacetylase(HDAC) Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Histone Deacetylase(HDAC) Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Histone Deacetylase(HDAC) Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Histone Deacetylase(HDAC) Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Histone Deacetylase(HDAC) Inhibitors Consumption Forecast (2022-2028)
9 Global Histone Deacetylase(HDAC) Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Histone Deacetylase(HDAC) Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Hydroxamic Acids Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Cyclic Tetrapeptides Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Benzamides Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Electrophilic Ketones Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Aliphatic Acid Consumption and Growth Rate (2017-2022)
-
9.2 Global Histone Deacetylase(HDAC) Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Psychiatry and Neurology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Treatment Consumption and Growth Rate (2017-2022)
-
9.2.3 Global HIV Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Histone Deacetylase(HDAC) Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Histone Deacetylase(HDAC) Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Hydroxamic Acids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Cyclic Tetrapeptides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Benzamides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Electrophilic Ketones Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Aliphatic Acid Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Histone Deacetylase(HDAC) Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Psychiatry and Neurology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global HIV Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Histone Deacetylase(HDAC) Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Histone Deacetylase(HDAC) Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Histone Deacetylase(HDAC) Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Histone Deacetylase(HDAC) Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Histone Deacetylase(HDAC) Inhibitors Market Competitive Analysis
-
14.1 Karus Therapeutics
-
14.1.1 Karus Therapeutics Company Details
-
14.1.2 Karus Therapeutics Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Karus Therapeutics Histone Deacetylase(HDAC) Inhibitors Product and Service
-
14.2 Signal Rx
-
14.2.1 Signal Rx Company Details
-
14.2.2 Signal Rx Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Signal Rx Histone Deacetylase(HDAC) Inhibitors Product and Service
-
14.3 Spectrum Pharmaceuticals
-
14.3.1 Spectrum Pharmaceuticals Company Details
-
14.3.2 Spectrum Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Spectrum Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Product and Service
-
14.4 Quimatryx
-
14.4.1 Quimatryx Company Details
-
14.4.2 Quimatryx Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Quimatryx Histone Deacetylase(HDAC) Inhibitors Product and Service
-
14.5 Gloucester Pharmaceuticals
-
14.5.1 Gloucester Pharmaceuticals Company Details
-
14.5.2 Gloucester Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Gloucester Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Product and Service
-
14.6 Pharmacyclics
-
14.6.1 Pharmacyclics Company Details
-
14.6.2 Pharmacyclics Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pharmacyclics Histone Deacetylase(HDAC) Inhibitors Product and Service
-
14.7 Ventana Medical Systems
-
14.7.1 Ventana Medical Systems Company Details
-
14.7.2 Ventana Medical Systems Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Ventana Medical Systems Histone Deacetylase(HDAC) Inhibitors Product and Service
-
14.8 SpeBio
-
14.8.1 SpeBio Company Details
-
14.8.2 SpeBio Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 SpeBio Histone Deacetylase(HDAC) Inhibitors Product and Service
-
14.9 Mirati Therapeutics
-
14.9.1 Mirati Therapeutics Company Details
-
14.9.2 Mirati Therapeutics Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Mirati Therapeutics Histone Deacetylase(HDAC) Inhibitors Product and Service
-
14.10 Onyx
-
14.10.1 Onyx Company Details
-
14.10.2 Onyx Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Onyx Histone Deacetylase(HDAC) Inhibitors Product and Service
-
14.11 TetraLogic Pharmaceuticals
-
14.11.1 TetraLogic Pharmaceuticals Company Details
-
14.11.2 TetraLogic Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 TetraLogic Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Histone Deacetylase(HDAC) Inhibitors
-
Figure Histone Deacetylase(HDAC) Inhibitors Picture
-
Table Global Histone Deacetylase(HDAC) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Histone Deacetylase(HDAC) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Histone Deacetylase(HDAC) Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Histone Deacetylase(HDAC) Inhibitors Consumption by Country (2017-2022)
-
Figure United States Histone Deacetylase(HDAC) Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Histone Deacetylase(HDAC) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Histone Deacetylase(HDAC) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Histone Deacetylase(HDAC) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Histone Deacetylase(HDAC) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Histone Deacetylase(HDAC) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Histone Deacetylase(HDAC) Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Histone Deacetylase(HDAC) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Histone Deacetylase(HDAC) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Histone Deacetylase(HDAC) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Histone Deacetylase(HDAC) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Histone Deacetylase(HDAC) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Histone Deacetylase(HDAC) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hydroxamic Acids Consumption and Growth Rate (2017-2022)
-
Figure Global Cyclic Tetrapeptides Consumption and Growth Rate (2017-2022)
-
Figure Global Benzamides Consumption and Growth Rate (2017-2022)
-
Figure Global Electrophilic Ketones Consumption and Growth Rate (2017-2022)
-
Figure Global Aliphatic Acid Consumption and Growth Rate (2017-2022)
-
Figure Global Psychiatry and Neurology Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global HIV Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hydroxamic Acids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cyclic Tetrapeptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Benzamides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Electrophilic Ketones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aliphatic Acid Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psychiatry and Neurology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HIV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Histone Deacetylase(HDAC) Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Histone Deacetylase(HDAC) Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Karus Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Karus Therapeutics Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Karus Therapeutics Histone Deacetylase(HDAC) Inhibitors Product and Service
-
Table Signal Rx (Foundation Year, Company Profile and etc.)
-
Table Signal Rx Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Signal Rx Histone Deacetylase(HDAC) Inhibitors Product and Service
-
Table Spectrum Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Spectrum Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spectrum Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Product and Service
-
Table Quimatryx (Foundation Year, Company Profile and etc.)
-
Table Quimatryx Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quimatryx Histone Deacetylase(HDAC) Inhibitors Product and Service
-
Table Gloucester Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Gloucester Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gloucester Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Product and Service
-
Table Pharmacyclics (Foundation Year, Company Profile and etc.)
-
Table Pharmacyclics Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharmacyclics Histone Deacetylase(HDAC) Inhibitors Product and Service
-
Table Ventana Medical Systems (Foundation Year, Company Profile and etc.)
-
Table Ventana Medical Systems Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ventana Medical Systems Histone Deacetylase(HDAC) Inhibitors Product and Service
-
Table SpeBio (Foundation Year, Company Profile and etc.)
-
Table SpeBio Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table SpeBio Histone Deacetylase(HDAC) Inhibitors Product and Service
-
Table Mirati Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Mirati Therapeutics Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mirati Therapeutics Histone Deacetylase(HDAC) Inhibitors Product and Service
-
Table Onyx (Foundation Year, Company Profile and etc.)
-
Table Onyx Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Onyx Histone Deacetylase(HDAC) Inhibitors Product and Service
-
Table TetraLogic Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table TetraLogic Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table TetraLogic Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Product and Service
-
